Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4443619
Max Phase: Preclinical
Molecular Formula: C24H27ClN4O4
Molecular Weight: 470.96
Molecule Type: Unknown
Associated Items:
ID: ALA4443619
Max Phase: Preclinical
Molecular Formula: C24H27ClN4O4
Molecular Weight: 470.96
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1=C(CC(=O)NCc2cc(Cl)ccc2CN)C(=O)N(NCc2cccc(C(=O)O)c2)CC1
Standard InChI: InChI=1S/C24H27ClN4O4/c1-15-7-8-29(28-13-16-3-2-4-17(9-16)24(32)33)23(31)21(15)11-22(30)27-14-19-10-20(25)6-5-18(19)12-26/h2-6,9-10,28H,7-8,11-14,26H2,1H3,(H,27,30)(H,32,33)
Standard InChI Key: YWILLTRBAXHNHO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 470.96 | Molecular Weight (Monoisotopic): 470.1721 | AlogP: 2.76 | #Rotatable Bonds: 9 |
Polar Surface Area: 124.76 | Molecular Species: ZWITTERION | HBA: 5 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.13 | CX Basic pKa: 8.85 | CX LogP: -0.46 | CX LogD: -0.47 |
Aromatic Rings: 2 | Heavy Atoms: 33 | QED Weighted: 0.45 | Np Likeness Score: -0.66 |
1. Andersson V, Bergström F, Brånalt J, Grönberg G, Gustafsson D, Karlsson S, Polla M, Bergman J, Kihlberg J.. (2016) Macrocyclic Prodrugs of a Selective Nonpeptidic Direct Thrombin Inhibitor Display High Permeability, Efficient Bioconversion but Low Bioavailability., 59 (14): [PMID:27347787] [10.1021/acs.jmedchem.5b01871] |
Source(1):